Showing results (21-30 of 41) with videos related to
Sort By:
Pageof 5
Immunology|August 1, 1997
Human monocyte-derived macrophages and dendritic cells are comparably effective in vitro in presenting HLA class I-restricted exogenous peptidesL Toujas, J G Delcros, E Diez, et al.The Journal of Experimental Medicine|May 3, 2000
A processed pseudogene codes for a new antigen recognized by a CD8(+) T cell clone on melanomaA Moreau-Aubry, S Le Guiner, N Labarrière, et al.European Journal of Immunology|January 1, 1993
Recognition of shared melanoma antigen by HLA-A2-restricted cytolytic T cell clones derived from human tumor-infiltrating lymphocytesC Viret, F Davodeau, Y Guilloux, et al.European Journal of Immunology|September 1, 1994
Defective lymphokine production by most CD8+ and CD4+ tumor-specific T cell clones derived from human melanoma-infiltrating lymphocytes in response to autologous tumor cells in vitroY Guilloux, C Viret, N Gervois, et al.European Journal of Immunology|May 16, 1998
LFA-3 co-stimulates cytokine secretion by cytotoxic T lymphocytes by providing a TCR-independent activation signalS Le Guiner, E Le Dréan, N Labarrière, et al.European Journal of Immunology|July 13, 2001
Comprehensive analysis of the frequency of recognition of melanoma-associated antigen (MAA) by CD8 melanoma infiltrating lymphocytes (TIL): implications for immunotherapyH Benlalam, N Labarrière, B Linard, et al.International Journal of Cancer|July 15, 1999
Mutated cytochrome b as a determinant of a new monoclonal antibody (H8.98) on renal carcinoma cell lines recognized by a Vgamma3Vdelta1(+) T-cell cloneA Choudhary, R A Kurt, F Goret, et al.Journal of Immunological Methods|October 31, 2001
Generation of high quantities of viral and tumor-specific human CD4+ and CD8+ T-cell clones using peptide pulsed mature dendritic cellsJ F Fonteneau, M Larsson, S Somersan, et al.Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|December 1, 1991
High-fold expansion of human cytotoxic T-lymphocytes specific for autologous melanoma cells for use in immunotherapyF Jotereau, M C Pandolfino, D Boudart, et al.International Journal of Cancer|October 1, 1998
Frequency and relative fraction of tumor antigen-specific T cells among lymphocytes from melanoma-invaded lymph nodesN Labarriere, M C Pandolfino, D Raingeard, et al.Pageof 5